| NCT ID | NCT02980640 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Swiss Multiple Sclerosis Registry |
| Condition | Multiple Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2016-06 |
| Primary Completion | 2041-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2016-06 with a primary completion date of 2041-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Swiss Multiple Sclerosis Registry is a national, patient-centered registry with the aim to document the epidemiology of multiple sclerosis (MS), as well as the quality of life of persons living with MS in Switzerland.
Eligibility Criteria
Inclusion Criteria: * Persons with a confirmed Multiple Sclerosis Diagnosis * 18 years and older * Living in Switzerland or receiving MS care in Switzerland Exclusion Criteria: * Younger than 18 years * Not living in Switzerland and not receiving MS care in Switzerland
Contact & Investigator
Milo Puhan, MD PhD
PRINCIPAL INVESTIGATOR
University of Zurich
Frequently Asked Questions
Who can join the NCT02980640 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02980640 currently recruiting?
Yes, NCT02980640 is actively recruiting participants. Contact the research team at miloalan.puhan@uzh.ch for enrollment information.
Where is the NCT02980640 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT02980640 clinical trial?
NCT02980640 is sponsored by Swiss Multiple Sclerosis Registry. The principal investigator is Milo Puhan, MD PhD at University of Zurich. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.